Swedencare AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0015988167
SEK
36.15
-1.35 (-3.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROCE of 3.19%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 9.42

 
3

Healthy long term growth as Net Sales has grown by an annual rate of 72.68% and Operating profit at 30.79%

4

With ROE of 1.02%, it has a attractive valuation with a 0.76 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 5,650 Million (Small Cap)

stock-summary
P/E

74.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

351.15%

stock-summary
Debt Equity

0.21

stock-summary
Return on Equity

1.00%

stock-summary
Price to Book

0.83

Revenue and Profits:
Net Sales:
647 Million
(Quarterly Results - Jun 2025)
Net Profit:
-7 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.66%
0%
-7.66%
6 Months
-8.6%
0%
-8.6%
1 Year
-29.6%
0%
-29.6%
2 Years
-38.65%
0%
-38.65%
3 Years
-2.61%
0%
-2.61%
4 Years
-73.08%
0%
-73.08%
5 Years
-36.36%
0%
-36.36%

Swedencare AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
72.68%
EBIT Growth (5y)
30.79%
EBIT to Interest (avg)
9.42
Debt to EBITDA (avg)
2.65
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.27
Tax Ratio
37.58%
Dividend Payout Ratio
40.14%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.19%
ROE (avg)
2.39%
Valuation key factors
Factor
Value
P/E Ratio
74
Industry P/E
Price to Book Value
0.76
EV to EBIT
38.71
EV to EBITDA
13.96
EV to Capital Employed
0.80
EV to Sales
2.62
PEG Ratio
NA
Dividend Yield
376.73%
ROCE (Latest)
2.08%
ROE (Latest)
1.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 2.57% vs 10.21% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -133.01% vs 28.22% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "646.70",
          "val2": "630.50",
          "chgp": "2.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "95.00",
          "val2": "139.10",
          "chgp": "-31.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.90",
          "val2": "21.90",
          "chgp": "-13.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.00",
          "val2": "-0.20",
          "chgp": "-2,400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.90",
          "val2": "20.90",
          "chgp": "-133.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.40%",
          "val2": "94.20%",
          "chgp": "-5.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.84% vs 27.06% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 68.77% vs -37.99% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,530.20",
          "val2": "2,324.60",
          "chgp": "8.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "537.40",
          "val2": "475.00",
          "chgp": "13.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "82.20",
          "val2": "93.20",
          "chgp": "-11.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.70",
          "val2": "-0.40",
          "chgp": "-325.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "98.90",
          "val2": "58.60",
          "chgp": "68.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "87.50%",
          "val2": "71.10%",
          "chgp": "1.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
646.70
630.50
2.57%
Operating Profit (PBDIT) excl Other Income
95.00
139.10
-31.70%
Interest
18.90
21.90
-13.70%
Exceptional Items
-5.00
-0.20
-2,400.00%
Consolidate Net Profit
-6.90
20.90
-133.01%
Operating Profit Margin (Excl OI)
35.40%
94.20%
-5.88%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 2.57% vs 10.21% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -133.01% vs 28.22% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,530.20
2,324.60
8.84%
Operating Profit (PBDIT) excl Other Income
537.40
475.00
13.14%
Interest
82.20
93.20
-11.80%
Exceptional Items
-1.70
-0.40
-325.00%
Consolidate Net Profit
98.90
58.60
68.77%
Operating Profit Margin (Excl OI)
87.50%
71.10%
1.64%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 8.84% vs 27.06% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 68.77% vs -37.99% in Dec 2023

stock-summaryCompany CV
About Swedencare AB stock-summary
stock-summary
Swedencare AB
Pharmaceuticals & Biotechnology
Swedencare publ AB is a Sweden-based company, which is mainly involved in the veterinary supplies industry. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores and pharmacies. It operates through four subsidiaries, namely SDC Distribution for Scandinavian countries, Buccosante located in France, Informpet in the United Kingdom and SwedencareUSA in the United States. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Powder, ProDen PlaqueOff Powder Cat and ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
Company Coordinates stock-summary
Company Details
Medeon Science Park , MALMO None : 205 12
Registrar Details